Influential factors in the adherence and abandonment of preventive therapy for latent tuberculosis infection in patients with HIV

被引：0
作者：
Bedoya Serna, Beatriz Eugenia [1 ]
机构：
[1] Corp Invest Biol, Medellin, Colombia
来源：
ARCHIVOS DE MEDICINA | 2019年 / 19卷 / 01期
关键词：
HIV; latent tuberculosis; chemoprevention; FAILURE; PREDICTORS; ADULTS; TRIAL;
D O I：
10.30554/archmed.19.1.2791.2019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: to describe the factors that influence the lack of adherence to the treatment of the latent tuberculosis infection. Materials and methods: retrospective and descriptive study in people living with the human immunodeficiency virus treated in a health institution of Medellin, Colombia. Results: 45% of patients presented adherence problems such as interruptions less than 30 days or loss of follow-up, the statistical significance (p < 0.05) was presented in the variables of adverse effects and adherence to antiretroviral treatment. Conclusion: adverse effects to treatment and adherence to antiretroviral therapy are associated with problems of adherence to preventive treatment of latent tuberculosis infection.
引用
收藏
页数：12
相关论文
共 50 条
[31]   The role of adherence to antiretroviral therapy in the management of HIV infection [J].
Conway, Brian .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 :S14-S18
[32]   Latent tuberculosis infection in persons with HIV/AIDS, associated factors, and progression to active disease in a city in southern Brazil [J].
dos Santos, Danielle Talita ;
Garcia, Maria Concebida ;
Nunes Fragoso da Costa, Arlete Alves ;
Pieri, Flavia Meneguetti ;
Pereira Meier, Denise Andrade ;
Ribeiro Albanese, Silvia Paulino ;
Arcencio, Ricardo Alexandre ;
Dessunti, Elma Mathias .
CADERNOS DE SAUDE PUBLICA, 2017, 33 (08)
[33]   Uptake of isoniazid preventive therapy for tuberculosis among HIV patients in Kano, Nigeria [J].
Jalo, Rabiu Ibrahim .
NIGERIAN JOURNAL OF BASIC AND CLINICAL SCIENCES, 2020, 17 (01) :57-63
[34]   The Effects of HIV-1 Infection on Latent Tuberculosis [J].
Bauer, Amy L. ;
Hogue, Ian B. ;
Marino, Simeone ;
Kirschner, Denise E. .
MATHEMATICAL MODELLING OF NATURAL PHENOMENA, 2008, 3 (07) :229-266
[35]   Treatment of Latent Tuberculosis Infection in HIV: Shorter or Longer? [J].
Anna K. Person ;
Timothy R. Sterling .
Current HIV/AIDS Reports, 2012, 9 :259-266
[36]   HIV infection as a risk factor for activation of latent tuberculosis [J].
Franco-Paredes, C .
INFECTIONS IN MEDICINE, 2002, 19 (10) :475-479
[37]   Factors associated with treatment adherence for tuberculosis infection [J].
Gallardo, Carmen R. ;
Gea Velazquez de Castro, Maria Teresa ;
Requena Puche, Juana ;
Miralles Bueno, Juan Jose ;
Rigo Medrano, Maria Vicenta ;
Aranaz Andres, Jesus M. .
ATENCION PRIMARIA, 2014, 46 (01) :6-14
[38]   Treatment of latent tuberculosis infection in HIV infected persons [J].
Akolo, Christopher ;
Adetifa, Ifedayo ;
Shepperd, Sasha ;
Volmink, Jimmy .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01)
[39]   Pregnancy in Women With HIV in a Tuberculosis Preventive Therapy Trial [J].
Singh, Priya ;
Moulton, Lawrence H. ;
Barnes, Grace L. ;
Gupta, Amita ;
Msandiwa, Reginah ;
Chaisson, Richard E. ;
Martinson, Neil A. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 91 (04) :397-402
[40]   Tuberculosis in patients with HIV infection [J].
Uriz, J. ;
Reparaz, J. ;
Castiello, I. ;
Sola, J. .
ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2007, 30 :131-142
12345